Q2 EPS Forecast for Daré Bioscience Lifted by Analyst
Daré Bioscience, Inc. (NASDAQ:DARE – Free Report) – Equities research analysts at Brookline Capital Management raised their Q2 2025 earnings per share estimates for Daré Bioscience in a report issued on Tuesday, May 13th. Brookline Capital Management analyst K. Dolliver now expects that the biotechnology company will post earnings per share of ($0.48) for the […]
Daré Bioscience, Inc. (NASDAQ:DARE – Free Report) – Equities research analysts at Brookline Capital Management raised their Q2 2025 earnings per share estimates for Daré Bioscience in a report issued on Tuesday, May 13th. Brookline Capital Management analyst K. Dolliver now expects that the biotechnology company will post earnings per share of ($0.48) for the […]
